speb/financial-data huggingface dataset:
Financial ratios for SANM — quarterly report dated 2025-12-31
Total revenue: 3189693000
Gross profit: 242362000
Operating income: 117631000
Net income: 51755000
Capital expenditures: 86837000
Operating cash flow: 178728000
Depreciation & amortization: 39531000
Net tangible assets: 2166891000
Owner earnings: 4449000
Return on net tangible assets (%): 0.2053172033111033
Capex to operating income (%): 73.82152663838613
Buffett classification: The Good
Stock price: 150.07
P/E ratio: 32.547159569014006
Shares outstanding: 53597735
Book value: 2661297000
P/B ratio: 3.0223654449127624
Market cap (USD): 8043412091.45
Debt to equity: 0.815617723237955
Current ratio: 1.701404093005318
Quick ratio: 1.0398844312616253
Effective tax rate (%): 15.957585008606411
Interest coverage ratio: 4.758150635061888
COGS to revenue (%): 92.4017138953498
R&D to revenue (%): 0.27143678090650103
SG&A to revenue (%): 3.6017886360850406
Free cash flow (dilution-adjusted): 68272000
Buyback yield (%): 0.9920416745129789
Retained earnings: -2412293000
Inventory turnover: 0.9653249163746508
Receivables turnover: 1.0366330687227125
Capitalized R&D asset: 17131970
ROCI (R&D-adjusted, %): 2.2645953292946537
Rosenberg metric: 5.906678971046257
FCF margin (%): 2.140394075542693
Revenue growth (%): 52.15155371705292
Rule of 40 score: 54.291947792595614
Financial ratios for SHFS — annual report dated 2021-12-31
Capital expenditures: 5920
Depreciation & amortization: 1921
Buffett classification: The Gruesome
Stock price: 201.4
Shares outstanding: 6455796
Market cap (USD): 1300197314.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHFS — annual report dated 2022-12-31
Total revenue: -32606724
Net income: -35128083
Capital expenditures: 17318
Operating cash flow: 1697380
Depreciation & amortization: 189274
Net tangible assets: -24774238
Owner earnings: -34956127
Buffett classification: The Gruesome
Stock price: 35.5
Shares outstanding: 6455796
Book value: 5113125
P/B ratio: 44.82205265859919
Market cap (USD): 229180758
Debt to equity: 0.20109678523407895
Free cash flow (dilution-adjusted): -1126274
Buyback yield (%): 0
Retained earnings: -39695281
Receivables turnover: -5.410713592328062
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHFS — annual report dated 2023-12-31
Total revenue: 14614247
Net income: -17279847
Capital expenditures: 208434
Operating cash flow: -832144
Depreciation & amortization: 1373707
Net tangible assets: 24575566
Owner earnings: -16114574
Return on net tangible assets (%): -65.57152742687595
Buffett classification: The Gruesome
Stock price: 28.4
Shares outstanding: 6455796
Book value: 34355311
P/B ratio: 5.336717993907841
Market cap (USD): 183344606.39999998
Debt to equity: 0.43717138814432505
COGS to revenue (%): 0
SG&A to revenue (%): 117.94804070302082
Free cash flow (dilution-adjusted): -4779734
Buyback yield (%): 0
Retained earnings: -71569821
Receivables turnover: 2.144361952319493
Capitalized R&D asset: 0
FCF margin (%): -32.705988888787765
Rule of 40 score: -32.705988888787765
Financial ratios for SHFS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.06
Shares outstanding: 6455796
Market cap (USD): 71401103.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHFS — annual report dated 2024-12-31
Total revenue: 17512808
Net income: -48319475
Capital expenditures: 0
Operating cash flow: 430477
Depreciation & amortization: 711929
Net tangible assets: -12288014
Owner earnings: -47607546
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 6455796
Book value: -12288014
Market cap (USD): 58102164
Debt to equity: -0.9667149630526137
COGS to revenue (%): 0
SG&A to revenue (%): 68.8633256300189
Free cash flow (dilution-adjusted): -1145475
Buyback yield (%): 0
Retained earnings: -120755545
Receivables turnover: 3.070713630940817
Capitalized R&D asset: 0
FCF margin (%): -6.540784321965957
Revenue growth (%): 19.83380327429802
Rule of 40 score: 13.293018952332062
Financial ratios for SHFS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9
Shares outstanding: 6455796
Market cap (USD): 58102164
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHFS — quarterly report dated 2025-03-31
Total revenue: 2935648
Net income: -827199
Capital expenditures: 0
Operating cash flow: -1140730
Depreciation & amortization: 1441
Net tangible assets: -16949407
Owner earnings: -825758
Buffett classification: The Gruesome
Stock price: 4.29
Shares outstanding: 6455796
Book value: -16949407
Market cap (USD): 27695364.84
Debt to equity: -0.6834024340792572
COGS to revenue (%): 0
SG&A to revenue (%): 82.58186948844003
Free cash flow (dilution-adjusted): -1890757
Buyback yield (%): 0
Retained earnings: -121069172
Receivables turnover: 4.0337412902099965
Capitalized R&D asset: 0
FCF margin (%): -64.40680217791778
Rule of 40 score: -64.40680217791778
Financial ratios for SHFS — quarterly report dated 2025-06-30
Total revenue: 1868151
Net income: -930715
Capital expenditures: 0
Operating cash flow: -674608
Depreciation & amortization: 1077
Net tangible assets: -17859171
Owner earnings: -929638
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 6455796
Book value: -17859171
Market cap (USD): 14009077.32
Debt to equity: -0.6463290485319839
COGS to revenue (%): 0
SG&A to revenue (%): 112.62681656889619
Free cash flow (dilution-adjusted): -708343
Buyback yield (%): 0
Retained earnings: -122513459
Receivables turnover: 2.937829358620527
Capitalized R&D asset: 0
FCF margin (%): -37.91679580505002
Revenue growth (%): -36.36324927239233
Rule of 40 score: -74.28004507744235
Financial ratios for SHFS — quarterly report dated 2025-09-30
Total revenue: 923713
Net income: 179508
Capital expenditures: 0
Operating cash flow: -538037
Depreciation & amortization: 637
Net tangible assets: 6996611
Owner earnings: 180145
Return on net tangible assets (%): 2.574746545148787
Buffett classification: The Gruesome
Stock price: 7.16
P/E ratio: 64.37526372083695
Shares outstanding: 6455796
Book value: 6996611
P/B ratio: 6.606555568117193
Market cap (USD): 46223499.36
Debt to equity: 0.10768513498892535
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 282.4149925355603
Free cash flow (dilution-adjusted): -1134155
Buyback yield (%): 0
Retained earnings: -122333951
Receivables turnover: 0.1394373013457767
Capitalized R&D asset: 0
FCF margin (%): -122.78218450969078
Revenue growth (%): -50.55469284870442
Rule of 40 score: -173.3368773583952
Financial ratios for SHFS — annual report dated 2025-12-31
Total revenue: 11837973
Net income: -2160998
Capital expenditures: 0
Operating cash flow: -3417700
Depreciation & amortization: 129072
Net tangible assets: 8235908
Owner earnings: -2031926
Return on net tangible assets (%): -24.67154805517497
Buffett classification: The Gruesome
Stock price: 1.06
Shares outstanding: 6455796
Book value: 8235908
P/B ratio: 0.8308912338505967
Market cap (USD): 6843143.760000001
Debt to equity: 0.08627039058717023
COGS to revenue (%): 0
SG&A to revenue (%): 82.72839446415362
Free cash flow (dilution-adjusted): -4941189
Buyback yield (%): 4.278735187641301
Retained earnings: -122916543
Receivables turnover: 2.8604093840392273
Capitalized R&D asset: 0
FCF margin (%): -41.740161090078516
Revenue growth (%): -32.40391261070184
Rule of 40 score: -74.14407370078035
Financial ratios for SHFS — quarterly report dated 2025-12-31
Total revenue: 6110461
Net income: -582592
Capital expenditures: 0
Operating cash flow: -1064325
Depreciation & amortization: 0
Net tangible assets: 8235908
Owner earnings: -582592
Return on net tangible assets (%): -7.073804127000933
Buffett classification: The Gruesome
Stock price: 1.06
Shares outstanding: 6455796
Book value: 8235908
P/B ratio: 0.8308912338505967
Market cap (USD): 6843143.760000001
Debt to equity: 0.08627039058717023
COGS to revenue (%): 0
SG&A to revenue (%): 43.47149912257029
Free cash flow (dilution-adjusted): -1207934
Buyback yield (%): 0
Retained earnings: -122916543
Receivables turnover: 1.4764706749378225
Capitalized R&D asset: 0
FCF margin (%): -19.768295714513194
Revenue growth (%): 561.5107722853311
Rule of 40 score: 541.7424765708179
Financial ratios for SQN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.373626373626372
Shares outstanding: 149883120
Market cap (USD): 3053662686.593406
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SQN.SW — annual report dated 2022-12-31
Total revenue: 443637466.3043478
Net income: 171080170.6521739
Capital expenditures: 56228869.56521739
Operating cash flow: 534521439.13043475
Depreciation & amortization: 35616700
Net tangible assets: 668678478.2608695
Owner earnings: 150468001.0869565
Return on net tangible assets (%): 22.50229459729297
Buffett classification: The Gruesome
Stock price: 13.652173913043478
P/E ratio: 11.960652208079638
Shares outstanding: 149883120
Book value: 805574015.217392
P/B ratio: 2.5400899013821467
Market cap (USD): 2046230420.8695652
Debt to equity: 0.018201709136666445
Effective tax rate (%): 15.555469104675899
COGS to revenue (%): 0
SG&A to revenue (%): 6.618995397948671
Free cash flow (dilution-adjusted): 478292569.5652174
Buyback yield (%): 0.9253713147212119
Retained earnings: 787853309.7826086
Receivables turnover: 11.801081146254436
Capitalized R&D asset: 0
FCF margin (%): 107.81158172900915
Rule of 40 score: 107.81158172900915
Financial ratios for SQN.SW — annual report dated 2023-12-31
Total revenue: 631986497.6190476
Net income: 259083633.33333334
Capital expenditures: 63202625
Operating cash flow: 348448697.61904764
Depreciation & amortization: 45224982.14285714
Net tangible assets: 900537254.7619048
Owner earnings: 241105990.4761905
Return on net tangible assets (%): 26.773572020619746
Buffett classification: The Gruesome
Stock price: 23.190476190476193
P/E ratio: 13.41598031876561
Shares outstanding: 149883120
Book value: 1069708326.1904774
P/B ratio: 3.249353903874688
Market cap (USD): 3475860925.7142863
Debt to equity: 0.014517838181421298
Effective tax rate (%): 14.800932234803879
COGS to revenue (%): 0
SG&A to revenue (%): 5.529270104320229
Free cash flow (dilution-adjusted): 285246072.61904764
Buyback yield (%): 1.3003893071537467
Retained earnings: 1086153233.3333335
Receivables turnover: 12.908550516895298
Capitalized R&D asset: 0
FCF margin (%): 45.13483653427512
Revenue growth (%): 42.455618747377635
Rule of 40 score: 87.59045528165275
Financial ratios for SQN.SW — annual report dated 2024-12-31
Total revenue: 738145210
Net income: 326858521.1111111
Capital expenditures: 62788730
Operating cash flow: 2245632783.3333335
Depreciation & amortization: 50912347.777777776
Net tangible assets: 1083533151.1111112
Owner earnings: 314982138.8888889
Return on net tangible assets (%): 29.069912495606605
Buffett classification: The Gruesome
Stock price: 37.41111111111111
P/E ratio: 17.15511052592041
Shares outstanding: 149883120
Book value: 1258924205.5555573
P/B ratio: 4.45403625671454
Market cap (USD): 5607294056
Debt to equity: 0.009618234143360759
Effective tax rate (%): 14.870732653847218
COGS to revenue (%): 0
SG&A to revenue (%): 5.222716573913989
Free cash flow (dilution-adjusted): 2182844053.3333335
Buyback yield (%): 0.5413346680862329
Retained earnings: 1272903206.6666667
Receivables turnover: 13.034573359155365
Capitalized R&D asset: 0
FCF margin (%): 295.7201406662699
Revenue growth (%): 16.79762349051693
Rule of 40 score: 312.5177641567868
Financial ratios for SQN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1083533151.1111112
Buffett classification: The Gruesome
Stock price: 37.41111111111111
Shares outstanding: 149883120
Book value: 1258924205.5555573
P/B ratio: 4.45403625671454
Market cap (USD): 5607294056
Debt to equity: 0.009618234143360759
Buyback yield (%): 0
Retained earnings: 1272903206.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SQN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1284012700
Buffett classification: The Gruesome
Stock price: 55.0875
Shares outstanding: 149883120
Book value: 1493776023.75
P/B ratio: 5.52739248838141
Market cap (USD): 8256686373
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 1519911346.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TGEN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2
Shares outstanding: 29917952
Market cap (USD): 35901542.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TGEN — annual report dated 2022-12-31
Total revenue: 25002614
Gross profit: 11066811
Operating income: -2386398
Net income: -2397712
Capital expenditures: 242224
Operating cash flow: -1351929
Depreciation & amortization: 428348
Net tangible assets: 15690560
Owner earnings: -2211588
Return on net tangible assets (%): -14.095022739787492
Buffett classification: The Gruesome
Stock price: 1.25
Shares outstanding: 29917952
Book value: 18987750
P/B ratio: 1.9695561612092007
Market cap (USD): 37397440
Debt to equity: 0.06904667482982449
Current ratio: 2.8662100979402365
Quick ratio: 1.5023937332819868
Interest coverage ratio: -46.82149584052739
COGS to revenue (%): 55.73738409911859
R&D to revenue (%): 2.931185515242526
SG&A to revenue (%): 50.87602440288843
Free cash flow (dilution-adjusted): -2030462
Buyback yield (%): 0
Retained earnings: -38281548
Inventory turnover: 1.3294060163150263
Receivables turnover: 2.708043923346108
Capitalized R&D asset: 732873
ROCI (R&D-adjusted, %): -8.910181080133206
FCF margin (%): -8.120998868358324
Rule of 40 score: -8.120998868358324
Financial ratios for TGEN — annual report dated 2023-12-31
Total revenue: 25139419
Gross profit: 10201618
Operating income: -4449819
Net income: -4523156
Capital expenditures: 12196
Operating cash flow: -817810
Depreciation & amortization: 567712
Net tangible assets: 9566943
Owner earnings: -3967640
Return on net tangible assets (%): -41.472390919439995
Buffett classification: The Gruesome
Stock price: 0.81
Shares outstanding: 29917952
Book value: 14652295
P/B ratio: 1.6539075359866835
Market cap (USD): 24233541.12
Debt to equity: 0.10089102082643026
Current ratio: 1.9370156708161312
Quick ratio: 0.9302788244131004
Interest coverage ratio: -57.75010706916019
COGS to revenue (%): 59.419833847393214
R&D to revenue (%): 3.3414097597084482
SG&A to revenue (%): 54.93932059448152
Free cash flow (dilution-adjusted): -1115055
Buyback yield (%): 0
Retained earnings: -42879656
Inventory turnover: 1.415446596027316
Receivables turnover: 3.1267871854981384
Capitalized R&D asset: 1331035.9100000001
ROCI (R&D-adjusted, %): -22.177630936514564
Rosenberg metric: -1.1805496996068896
FCF margin (%): -4.435484368194826
Revenue growth (%): 0.5471627886588178
Rule of 40 score: -3.8883215795360084
Financial ratios for TGEN — quarterly report dated 2024-09-30
Total revenue: 5630130
Gross profit: 2480914
Operating income: -877265
Net income: -895930
Capital expenditures: 282296
Operating cash flow: -207292
Depreciation & amortization: 138246
Net tangible assets: 6136063
Owner earnings: -1039980
Return on net tangible assets (%): -16.9486525806531
Buffett classification: The Gruesome
Stock price: 0.84
Shares outstanding: 29917952
Book value: 11193204
P/B ratio: 2.245208760601522
Market cap (USD): 25131079.68
Debt to equity: 0.3404084299723296
Current ratio: 1.5344905215201479
Quick ratio: 0.6987547525843663
Interest coverage ratio: -38.13698213276529
COGS to revenue (%): 55.93504945711734
R&D to revenue (%): 4.1528170752717966
SG&A to revenue (%): 55.493745259878544
Free cash flow (dilution-adjusted): -531496
Buyback yield (%): 0
Retained earnings: -46453827
Inventory turnover: 0.31825609642467995
Receivables turnover: 0.8546173163632212
Capitalized R&D asset: 233809
ROCI (R&D-adjusted, %): -4.5445016793437185
FCF margin (%): -9.440208307801063
Rule of 40 score: -9.440208307801063
Financial ratios for TGEN — annual report dated 2024-12-31
Total revenue: 22619536
Gross profit: 9870173
Operating income: -4328973
Net income: -4673770
Capital expenditures: 917763
Operating cash flow: 4060547
Depreciation & amortization: 553783
Net tangible assets: 5370590
Owner earnings: -5037750
Return on net tangible assets (%): -93.80254310978869
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 29917952
Book value: 10125538
P/B ratio: 4.343412610766953
Market cap (USD): 43979389.44
Debt to equity: 0.3685655023960208
Current ratio: 1.3169468391129282
Quick ratio: 0.7440260220333552
Interest coverage ratio: -36.96249082122304
COGS to revenue (%): 56.36438784597526
R&D to revenue (%): 4.2522401874202895
SG&A to revenue (%): 58.52157621624069
Free cash flow (dilution-adjusted): 2918397
Buyback yield (%): 0
Retained earnings: -47639894
Inventory turnover: 1.3233710175570803
Receivables turnover: 3.5203076270383225
Capitalized R&D asset: 1766492.4600000002
ROCI (R&D-adjusted, %): -26.254454807857353
Rosenberg metric: -0.3945722139352937
FCF margin (%): 12.902108159955183
Revenue growth (%): -10.02363260662468
Rule of 40 score: 2.878475553330503
Financial ratios for TGEN — quarterly report dated 2024-12-31
Total revenue: 6075522
Gross profit: 2734447
Operating income: -923828
Net income: -1179748
Capital expenditures: 78831
Operating cash flow: 4177542
Depreciation & amortization: 134039
Net tangible assets: 5370590
Owner earnings: -1124540
Return on net tangible assets (%): -20.9388540179012
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 29917952
Book value: 10125538
P/B ratio: 4.343412610766953
Market cap (USD): 43979389.44
Debt to equity: 0.3685655023960208
Current ratio: 1.3169468391129282
Quick ratio: 0.7440260220333552
Interest coverage ratio: -21.854888694376758
COGS to revenue (%): 54.9923940691845
R&D to revenue (%): 3.7337203288869665
SG&A to revenue (%): 56.47962430224103
Free cash flow (dilution-adjusted): 4006230
Buyback yield (%): 0
Retained earnings: -47639894
Inventory turnover: 0.3468002144487158
Receivables turnover: 0.9455413424412916
Capitalized R&D asset: 383495.03
ROCI (R&D-adjusted, %): -5.801681434307613
Rosenberg metric: 1.0843594557951148
FCF margin (%): 65.94050684039988
Revenue growth (%): 7.9108652908547406
Rule of 40 score: 73.85137213125462
Financial ratios for TGEN — quarterly report dated 2025-03-31
Total revenue: 7277770
Gross profit: 3221040
Operating income: -594244
Net income: -659922
Capital expenditures: 132020
Operating cash flow: -1173403
Depreciation & amortization: 185695
Net tangible assets: 4881835
Owner earnings: -606247
Return on net tangible assets (%): -12.418424629263383
Buffett classification: The Gruesome
Stock price: 2.23
Shares outstanding: 29917952
Book value: 9511493
P/B ratio: 7.014359676235896
Market cap (USD): 66717032.96
Debt to equity: 0.41533731875742325
Current ratio: 1.3791816584576582
Quick ratio: 0.7177186059536124
Interest coverage ratio: -18.382849718492853
COGS to revenue (%): 55.74138781522362
R&D to revenue (%): 4.021396664088038
SG&A to revenue (%): 48.402408979673716
Free cash flow (dilution-adjusted): -1346256
Buyback yield (%): 0
Retained earnings: -48299816
Inventory turnover: 0.41031987255670466
Receivables turnover: 1.2177822577339064
Capitalized R&D asset: 521809.78
ROCI (R&D-adjusted, %): -3.612105098582437
Rosenberg metric: 2.1450650890704144
FCF margin (%): -18.49819381486362
Revenue growth (%): 19.78839019922897
Rule of 40 score: 1.290196384365352
Financial ratios for TGEN — quarterly report dated 2025-06-30
Total revenue: 7294820
Gross profit: 2462492
Operating income: -1412142
Net income: -1464105
Capital expenditures: 145969
Operating cash flow: -2602217
Depreciation & amortization: 205686
Net tangible assets: 4421306
Owner earnings: -1404388
Return on net tangible assets (%): -31.764098662250472
Buffett classification: The Gruesome
Stock price: 6.8
Shares outstanding: 29917952
Book value: 8941451
P/B ratio: 22.752691213092817
Market cap (USD): 203442073.6
Debt to equity: 0.4131039805508077
Current ratio: 1.3630819910511578
Quick ratio: 0.6700168675987656
Interest coverage ratio: -37.012607134432415
COGS to revenue (%): 66.24327947776642
R&D to revenue (%): 3.6837646439528324
SG&A to revenue (%): 49.4311031663564
Free cash flow (dilution-adjusted): -2790792
Buyback yield (%): 0
Retained earnings: -49763921
Inventory turnover: 0.4992472024373016
Receivables turnover: 1.07796390867093
Capitalized R&D asset: 539669.75
ROCI (R&D-adjusted, %): -9.42109982241845
Rosenberg metric: -2.5918378503970367
FCF margin (%): -38.25717426886476
Revenue growth (%): 0.23427505953059796
Rule of 40 score: -38.02289920933416
Financial ratios for TGEN — quarterly report dated 2025-09-30
Total revenue: 7183121
Gross profit: 2183566
Operating income: -2098991
Net income: -2119066
Capital expenditures: 75307
Operating cash flow: -3560799
Depreciation & amortization: 230149
Net tangible assets: 20880163
Owner earnings: -1964224
Return on net tangible assets (%): -9.407129628250507
Buffett classification: The Gruesome
Stock price: 8.81
Shares outstanding: 29917952
Book value: 25317381
P/B ratio: 10.410917192422076
Market cap (USD): 263577157.12
Debt to equity: 0.1124763655450775
Current ratio: 2.7137755818111633
Quick ratio: 1.905170433736964
Interest coverage ratio: -51.05419210468708
COGS to revenue (%): 69.60143091004592
R&D to revenue (%): 4.147584316065398
SG&A to revenue (%): 55.47214087024289
Free cash flow (dilution-adjusted): -3762525
Buyback yield (%): 0
Retained earnings: -51894868
Inventory turnover: 0.5230708372096332
Receivables turnover: 1.1317029187297223
Capitalized R&D asset: 574551.52
ROCI (R&D-adjusted, %): -6.908061575145369
Rosenberg metric: -1.0379646030871823
FCF margin (%): -52.38008659467104
Revenue growth (%): -1.5312098173772624
Rule of 40 score: -53.9112964120483
Financial ratios for TGEN — annual report dated 2025-12-31
Total revenue: 27073710
Gross profit: 9824508
Operating income: -7131518
Net income: -8248755
Capital expenditures: 396491
Operating cash flow: -9911674
Depreciation & amortization: 877675
Net tangible assets: 18250701
Owner earnings: -7767571
Return on net tangible assets (%): -42.56039809101031
Buffett classification: The Gruesome
Stock price: 4.94
Shares outstanding: 29917952
Book value: 21472612
P/B ratio: 6.882939200875982
Market cap (USD): 147794682.88000003
Debt to equity: 0.13112885381620085
Current ratio: 3.11694893361762
Quick ratio: 1.9353915158376778
Interest coverage ratio: -47.452029090618744
COGS to revenue (%): 63.71199957449496
R&D to revenue (%): 4.309509114192329
SG&A to revenue (%): 58.3196096877746
Free cash flow (dilution-adjusted): -10660484
Buyback yield (%): 0
Retained earnings: -55888649
Inventory turnover: 1.5753131798989506
Receivables turnover: 6.126644627044377
Capitalized R&D asset: 2088378.42
ROCI (R&D-adjusted, %): -23.32774049595595
Rosenberg metric: -0.04747685938469824
FCF margin (%): -39.37577819958919
Revenue growth (%): 19.691712509045278
Rule of 40 score: -19.684065690543914
Financial ratios for TGEN — quarterly report dated 2025-12-31
Total revenue: 5317998
Gross profit: 1957409
Operating income: -3026141
Net income: -3993781
Capital expenditures: 43195
Operating cash flow: -2575255
Depreciation & amortization: 256145
Net tangible assets: 18250701
Owner earnings: -3780831
Return on net tangible assets (%): -20.716086467034884
Buffett classification: The Gruesome
Stock price: 4.94
Shares outstanding: 29917952
Book value: 21472612
P/B ratio: 6.882939200875982
Market cap (USD): 147794682.88000003
Debt to equity: 0.13112885381620085
Current ratio: 3.11694893361762
Quick ratio: 1.9353915158376778
Interest coverage ratio: -78.20091996795617
COGS to revenue (%): 63.19274659373697
R&D to revenue (%): 5.78085963928531
SG&A to revenue (%): 87.93015717568905
Free cash flow (dilution-adjusted): -2760911
Buyback yield (%): 0
Retained earnings: -55888649
Inventory turnover: 0.30691159764512205
Receivables turnover: 1.203436243992151
Capitalized R&D asset: 595715.3400000001
ROCI (R&D-adjusted, %): -10.629299638196136
Rosenberg metric: -0.759104609869565
FCF margin (%): -51.9163602543664
Revenue growth (%): -25.9653568414064
Rule of 40 score: -77.8817170957728
Financial ratios for THCH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.05
Shares outstanding: 32036529
Market cap (USD): 1571391747.4499998
Buyback yield (%): 0.001358673197029436
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THCH — annual report dated 2022-12-31
Total revenue: 145267782.47126436
Gross profit: 4748908.620689656
Operating income: -81196228.73563218
Net income: -106701901.14942528
Capital expenditures: 48122152.01149426
Operating cash flow: -41225339.655172415
Depreciation & amortization: 19167026.436781608
Net tangible assets: 1843733.764367816
Owner earnings: -135657026.72413793
Return on net tangible assets (%): -7357.73403654363
Buffett classification: The Gruesome
Stock price: 13.9
Shares outstanding: 32036529
Book value: 15848335.63218391
P/B ratio: 28.098076885480268
Market cap (USD): 445307753.1
Debt to equity: 16.059239205799337
Current ratio: 0.6044415684902252
Quick ratio: 0.5502281443034956
Interest coverage ratio: -38.17385001704269
COGS to revenue (%): 96.73092784931232
SG&A to revenue (%): 36.650684206202676
Free cash flow (dilution-adjusted): -100078340.94827586
Buyback yield (%): 0
Retained earnings: -198300774.71264368
Inventory turnover: 13.68469765082226
Receivables turnover: 11.825290054550097
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.69135133961194
FCF margin (%): -68.89231682742353
Rule of 40 score: -68.89231682742353
Financial ratios for THCH — annual report dated 2023-12-31
Total revenue: 219410099.43741208
Gross profit: 21988737.834036566
Operating income: -75962527.42616034
Net income: -122774463.15049227
Capital expenditures: 40983933.47398031
Operating cash flow: -27585074.683544304
Depreciation & amortization: 22946467.791842476
Net tangible assets: -75692398.59353024
Owner earnings: -140811928.8326301
Buffett classification: The Gruesome
Stock price: 8.75
Shares outstanding: 32036529
Book value: -59413391.70182842
Market cap (USD): 280319628.75
Debt to equity: -4.279308020871614
Current ratio: 0.3285634901967961
Quick ratio: 0.2928384028144576
Interest coverage ratio: -26.449254730364242
COGS to revenue (%): 89.97824717712733
SG&A to revenue (%): 27.047106626571683
Free cash flow (dilution-adjusted): -77675678.7623066
Buyback yield (%): 0
Retained earnings: -317359180.73136425
Inventory turnover: 28.148617987979645
Receivables turnover: 9.867184441026083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -65.89673458076048
FCF margin (%): -35.402052577103
Revenue growth (%): 51.038375959799566
Rule of 40 score: 15.636323382696567
Financial ratios for THCH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.05
Shares outstanding: 32036529
Market cap (USD): 129747942.44999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THCH — quarterly report dated 2024-12-31
Total revenue: 45565042.60273973
Gross profit: 6167857.94520548
Operating income: -13815724.246575342
Net income: -18021719.8630137
Capital expenditures: 0
Operating cash flow: -4332734.520547945
Depreciation & amortization: 4941619.452054795
Net tangible assets: -128480617.12328768
Owner earnings: -13080100.410958905
Buffett classification: The Gruesome
Stock price: 3.55
Shares outstanding: 32036529
Book value: -114111699.45205477
Market cap (USD): 113729677.94999999
Debt to equity: -2.254478908160794
Current ratio: 0.27154913859375185
Quick ratio: 0.2470829402004021
Interest coverage ratio: -27.212752340091182
COGS to revenue (%): 86.46361861442742
SG&A to revenue (%): 27.08279780127406
Free cash flow (dilution-adjusted): -18420211.506849315
Buyback yield (%): 0
Retained earnings: -365548675.34246576
Inventory turnover: 7.653315021402579
Receivables turnover: 1.948050612975228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -365.39182672677504
FCF margin (%): -40.426191779181494
Rule of 40 score: -40.426191779181494
Financial ratios for THCH — annual report dated 2024-12-31
Total revenue: 190569563.15068492
Gross profit: 29254844.246575344
Operating income: -39540655.75342466
Net income: -56025371.23287671
Capital expenditures: 12739600.95890411
Operating cash flow: -5433830.410958904
Depreciation & amortization: 23243940.95890411
Net tangible assets: -128480617.12328768
Owner earnings: -45521031.23287671
Buffett classification: The Gruesome
Stock price: 3.55
Shares outstanding: 32036529
Book value: -114111699.45205477
Market cap (USD): 113729677.94999999
Debt to equity: -2.254478908160794
Current ratio: 0.27154913859375185
Quick ratio: 0.2470829402004021
Interest coverage ratio: -12.85837235026712
COGS to revenue (%): 84.64873206250503
SG&A to revenue (%): 19.78000646829564
Free cash flow (dilution-adjusted): -19664459.178082194
Buyback yield (%): 0
Retained earnings: -365548675.34246576
Inventory turnover: 31.33707070934205
Receivables turnover: 8.147455441812566
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1045.7528087461465
FCF margin (%): -10.318782733700944
Revenue growth (%): -13.144580108516873
Rule of 40 score: -23.46336284221782
Financial ratios for THCH — quarterly report dated 2025-03-31
Total revenue: 41424517.90633609
Gross profit: 6128374.655647383
Operating income: -9773002.754820937
Net income: -7991873.278236914
Capital expenditures: 0
Operating cash flow: -30165.289256198346
Depreciation & amortization: 3906060.606060606
Net tangible assets: -136127410.46831957
Owner earnings: -4085812.6721763085
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 32036529
Book value: -122493526.17079887
Market cap (USD): 93867029.97
Debt to equity: -2.0873639243317523
Current ratio: 0.2705616217156821
Quick ratio: 0.2491594104553061
Interest coverage ratio: -19.84116331096197
COGS to revenue (%): 85.20592401460388
SG&A to revenue (%): 23.022723796476715
Free cash flow (dilution-adjusted): -30165.289256198346
Buyback yield (%): 0
Retained earnings: -375554545.45454544
Inventory turnover: 7.467579775608335
Receivables turnover: 8.802376631739156
Capitalized R&D asset: 0
FCF margin (%): -0.07281989213345658
Revenue growth (%): -9.087064249018558
Rule of 40 score: -9.159884141152014
Financial ratios for THCH — quarterly report dated 2025-06-30
Total revenue: 48671687.58716876
Gross profit: 8394560.669456067
Operating income: -5306415.620641562
Net income: -10523709.902370991
Capital expenditures: 0
Operating cash flow: -163877.26638772665
Depreciation & amortization: 3736262.2036262206
Net tangible assets: -147371687.58716875
Owner earnings: -6787447.69874477
Buffett classification: The Gruesome
Stock price: 2.96
Shares outstanding: 32036529
Book value: -134206694.56066945
Market cap (USD): 94828125.84
Debt to equity: -1.9128948249021578
Current ratio: 0.2583120732993799
Quick ratio: 0.2357256219146865
Interest coverage ratio: -7.875595114883047
COGS to revenue (%): 82.75268213286873
SG&A to revenue (%): 14.787263307505388
Free cash flow (dilution-adjusted): -163877.26638772665
Buyback yield (%): 0
Retained earnings: -390792329.1492329
Inventory turnover: 8.004739861961914
Receivables turnover: 13.653208137715179
Capitalized R&D asset: 0
FCF margin (%): -0.33669937187657606
Revenue growth (%): 17.494879957852635
Rule of 40 score: 17.15818058597606
Financial ratios for THCH — quarterly report dated 2025-09-30
Total revenue: 50283426.966292135
Gross profit: 8769943.82022472
Operating income: -7779775.2808988765
Net income: -10237921.348314608
Capital expenditures: 0
Operating cash flow: -240589.88764044942
Depreciation & amortization: 3731741.5730337077
Net tangible assets: -157713202.247191
Owner earnings: -6506179.7752809
Buffett classification: The Gruesome
Stock price: 2.59
Shares outstanding: 32036529
Book value: -144864466.29213485
Market cap (USD): 82974610.11
Debt to equity: -1.7429406603421445
Current ratio: 0.2452666605195395
Quick ratio: 0.22036398831385745
Interest coverage ratio: -13.018096357226794
COGS to revenue (%): 82.55897748157915
SG&A to revenue (%): 18.888156461406968
Free cash flow (dilution-adjusted): -240589.88764044942
Buyback yield (%): 0
Retained earnings: -403774578.6516854
Inventory turnover: 7.345145498372307
Receivables turnover: 17.256374415578158
Capitalized R&D asset: 0
FCF margin (%): -0.47846756308342037
Revenue growth (%): 3.3114516036388166
Rule of 40 score: 2.832984040555396
Financial ratios for THCH — annual report dated 2025-12-31
Total revenue: 188028067.7142857
Gross profit: 29901485.714285713
Operating income: -35794813.85714286
Net income: -62069785
Capital expenditures: 8976208.857142856
Operating cash flow: -1815262.5714285714
Depreciation & amortization: 20970780.57142857
Net tangible assets: -189142865
Owner earnings: -50075213.28571429
Buffett classification: The Gruesome
Stock price: 2.49
Shares outstanding: 32036529
Book value: -176633560.14285716
Market cap (USD): 79770957.21000001
Debt to equity: -1.5924001308597784
Current ratio: 0.3258884861863724
Quick ratio: 0.28917880284834135
Interest coverage ratio: -15.02264557259981
COGS to revenue (%): 84.09732861812849
SG&A to revenue (%): 20.346439706386874
Free cash flow (dilution-adjusted): -11600039.142857144
Buyback yield (%): 0
Retained earnings: -443284832.14285713
Inventory turnover: 30.08437576322839
Receivables turnover: 10.159331299012228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -143.65977191733242
FCF margin (%): -6.169312530767349
Revenue growth (%): -1.3336313492987546
Rule of 40 score: -7.502943880066104
Financial ratios for THCH — quarterly report dated 2025-12-31
Total revenue: 44065782
Gross profit: 6026771.428571428
Operating income: -12310385.285714285
Net income: -32454678
Capital expenditures: 0
Operating cash flow: -1371405.4285714286
Depreciation & amortization: 3744747.5714285714
Net tangible assets: -189142865
Owner earnings: -28709930.42857143
Buffett classification: The Gruesome
Stock price: 2.49
Shares outstanding: 32036529
Book value: -176633560.14285716
Market cap (USD): 79770957.21000001
Debt to equity: -1.5924001308597784
Current ratio: 0.3258884861863724
Quick ratio: 0.28917880284834135
Interest coverage ratio: -21.451650781938856
COGS to revenue (%): 86.32323958628166
SG&A to revenue (%): 25.719055985111407
Free cash flow (dilution-adjusted): -10745540
Buyback yield (%): 0
Retained earnings: -443284832.14285713
Inventory turnover: 7.2371126550517255
Receivables turnover: 2.3809151672414735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.40679813054241
FCF margin (%): -24.38522479868847
Revenue growth (%): -12.36519732527415
Rule of 40 score: -36.75042212396262
Financial ratios for TRGP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.32
Shares outstanding: 214643903
Market cap (USD): 10156949489.960001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRGP — annual report dated 2022-12-31
Total revenue: 20929800000
Gross profit: 2951700000
Operating income: 1729000000
Net income: 1531400000
Capital expenditures: 1334300000
Operating cash flow: 2380800000
Depreciation & amortization: 1096000000
Net tangible assets: -68900000
Owner earnings: 1293100000
Return on net tangible assets (%): -1876.7779390420899
Capex to operating income (%): 77.17177559282823
Buffett classification: The Gruesome
Stock price: 68
P/E ratio: 9.531007838579077
Shares outstanding: 214643903
Book value: 4982200000
P/B ratio: 2.929586408413954
Market cap (USD): 14595785404
Debt to equity: 2.3212636987676127
Current ratio: 0.7684481690416408
Quick ratio: 0.6400365213421593
Effective tax rate (%): 7.924482924482924
Interest coverage ratio: 3.875812598072181
COGS to revenue (%): 85.8971418742654
SG&A to revenue (%): 1.479708358417185
Free cash flow (dilution-adjusted): 989000000
Buyback yield (%): 8.15303847694197
Retained earnings: -626800000
Inventory turnover: 45.65286947689182
Receivables turnover: 14.860692984947459
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.483044630243796
FCF margin (%): 4.7253198788330515
Rule of 40 score: 4.7253198788330515
Financial ratios for TRGP — annual report dated 2023-12-31
Total revenue: 16060300000
Gross profit: 4054300000
Operating income: 2626200000
Net income: 1579300000
Capital expenditures: 2385400000
Operating cash flow: 3211600000
Depreciation & amortization: 1329600000
Net tangible assets: 389100000
Owner earnings: 523500000
Return on net tangible assets (%): 134.54124903623747
Capex to operating income (%): 90.8308582743127
Buffett classification: The Gruesome
Stock price: 82.28
P/E ratio: 11.182739402798708
Shares outstanding: 214643903
Book value: 4610000000
P/B ratio: 3.830997904303688
Market cap (USD): 17660900338.84
Debt to equity: 2.8222125813449024
Current ratio: 0.7948857256691658
Quick ratio: 0.6603281538628708
Effective tax rate (%): 18.697554697554697
Interest coverage ratio: 3.818261122419308
COGS to revenue (%): 74.75576421361993
SG&A to revenue (%): 2.171192318947965
Free cash flow (dilution-adjusted): 763800000
Buyback yield (%): 2.115973664027512
Retained earnings: 492000000
Inventory turnover: 32.31763122476447
Receivables turnover: 10.917946974847043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.662579769860812
FCF margin (%): 4.755826478957429
Revenue growth (%): -23.265869716863037
Rule of 40 score: -18.510043237905606
Financial ratios for TRGP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 142.72
Shares outstanding: 214643903
Market cap (USD): 30633977836.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRGP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 172.9
Shares outstanding: 214643903
Market cap (USD): 37111930828.700005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRGP — annual report dated 2024-12-31
Total revenue: 16381500000
Gross profit: 4255500000
Operating income: 2695400000
Net income: 1553500000
Capital expenditures: 2965800000
Operating cash flow: 3649700000
Depreciation & amortization: 1423000000
Net tangible assets: 615000000
Owner earnings: 10700000
Return on net tangible assets (%): 1.7398373983739839
Capex to operating income (%): 110.03190621058098
Buffett classification: The Gruesome
Stock price: 172.9
P/E ratio: 23.889237739748953
Shares outstanding: 214643903
Book value: 4418200000
P/B ratio: 8.399785167873794
Market cap (USD): 37111930828.700005
Debt to equity: 3.2286904169118644
Current ratio: 0.7237912122549328
Quick ratio: 0.6184202231608145
Effective tax rate (%): 19.840041279669762
Interest coverage ratio: 3.5132950990615224
COGS to revenue (%): 74.022525409761
SG&A to revenue (%): 2.349601684827397
Free cash flow (dilution-adjusted): 620700000
Buyback yield (%): 2.0335778364200956
Retained earnings: 1190000000
Inventory turnover: 36.27280885432246
Receivables turnover: 10.122659581041834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.779106919203537
FCF margin (%): 3.7890303085798003
Revenue growth (%): 1.9999626407974944
Rule of 40 score: 5.7889929493772945
Financial ratios for TRGP — quarterly report dated 2025-03-31
Total revenue: 4561500000
Gross profit: 936100000
Operating income: 543300000
Net income: 279800000
Capital expenditures: 792200000
Operating cash flow: 954400000
Depreciation & amortization: 367600000
Net tangible assets: 555400000
Owner earnings: -144800000
Return on net tangible assets (%): -26.07129996398992
Capex to operating income (%): 145.8126265415056
Buffett classification: The Gruesome
Stock price: 194.89
P/E ratio: 37.37665319484453
Shares outstanding: 214643903
Book value: 2572500000
P/B ratio: 16.26120515283576
Market cap (USD): 41831950255.67
Debt to equity: 6.300758017492711
Current ratio: 0.6491979612895157
Quick ratio: 0.5690878959382133
Effective tax rate (%): 20.511363636363637
COGS to revenue (%): 79.47824180642333
SG&A to revenue (%): 2.071686945083854
Free cash flow (dilution-adjusted): 144600000
Buyback yield (%): 0.29857560844433917
Retained earnings: 1295300000
Inventory turnover: 14.150663544106168
Receivables turnover: 3.2505522696501106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.771627674444705
FCF margin (%): 3.170009865175929
Rule of 40 score: 3.170009865175929
Financial ratios for TRGP — quarterly report dated 2025-06-30
Total revenue: 4260100000
Gross profit: 1450400000
Operating income: 1033600000
Net income: 637200000
Capital expenditures: 906100000
Operating cash flow: 858300000
Depreciation & amortization: 373700000
Net tangible assets: 773700000
Owner earnings: 104800000
Return on net tangible assets (%): 13.545301796561976
Capex to operating income (%): 87.66447368421053
Buffett classification: The Gruesome
Stock price: 170.19
P/E ratio: 39.83669122308615
Shares outstanding: 214643903
Book value: 2711400000
P/B ratio: 13.472835380825403
Market cap (USD): 36530245851.57
Debt to equity: 6.214686140001476
Current ratio: 0.6948090786035823
Quick ratio: 0.5551987911984134
Effective tax rate (%): 22.415682454645076
Interest coverage ratio: 4.732600732600733
COGS to revenue (%): 65.95385084857163
SG&A to revenue (%): 2.229994601065703
Free cash flow (dilution-adjusted): -64900000
Buyback yield (%): 0.8877575073480163
Retained earnings: 1705400000
Inventory turnover: 6.335287485907553
Receivables turnover: 3.0243504188556014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.0825871233914075
FCF margin (%): -1.5234384169385695
Revenue growth (%): -6.607475611092842
Rule of 40 score: -8.130914028031412
Financial ratios for TRGP — quarterly report dated 2025-09-30
Total revenue: 4151200000
Gross profit: 1261300000
Operating income: 836900000
Net income: 486600000
Capital expenditures: 671800000
Operating cash flow: 599200000
Depreciation & amortization: 383500000
Net tangible assets: 973900000
Owner earnings: 198300000
Return on net tangible assets (%): 20.361433412054623
Capex to operating income (%): 80.27243398255467
Buffett classification: The Gruesome
Stock price: 164.78
P/E ratio: 25.198790493260187
Shares outstanding: 214643903
Book value: 2833800000
P/B ratio: 12.481128638697156
Market cap (USD): 35369022336.340004
Debt to equity: 6.151210388877126
Current ratio: 0.7734799131378935
Quick ratio: 0.6069828990228013
Effective tax rate (%): 21.629892092124337
Interest coverage ratio: 3.781744238590149
COGS to revenue (%): 69.61601464636732
SG&A to revenue (%): 2.5245712083253036
Free cash flow (dilution-adjusted): -90100000
Buyback yield (%): 0.4399329970739065
Retained earnings: 1966200000
Inventory turnover: 5.889341756674139
Receivables turnover: 2.9489237763728067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9425088092860237
FCF margin (%): -2.1704567354018116
Revenue growth (%): -2.5562780216426844
Rule of 40 score: -4.726734757044496
Financial ratios for TRGP — quarterly report dated 2025-12-31
Total revenue: 4055500000
Gross profit: 1357400000
Operating income: 917400000
Net income: 553100000
Capital expenditures: 963200000
Operating cash flow: 1505500000
Depreciation & amortization: 390500000
Net tangible assets: 1416500000
Owner earnings: -19600000
Return on net tangible assets (%): -1.383692199082245
Capex to operating income (%): 104.99236974057118
Buffett classification: The Gruesome
Stock price: 182.67
P/E ratio: 20.038330741048703
Shares outstanding: 214643903
Book value: 3198200000
P/B ratio: 12.25970913670502
Market cap (USD): 39209001761.009995
Debt to equity: 5.478706772559565
Current ratio: 0.666149768805684
Quick ratio: 0.5451110860493966
Effective tax rate (%): 20.095348165270153
Interest coverage ratio: 4.247222222222222
COGS to revenue (%): 66.52940451239058
SG&A to revenue (%): 2.7542843052644557
Free cash flow (dilution-adjusted): 525000000
Buyback yield (%): 0.09436608517994288
Retained earnings: 2294400000
Inventory turnover: 6.284882366643373
Receivables turnover: 2.7502373525023733
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.233189981358091
FCF margin (%): 12.9453828134632
Revenue growth (%): -2.305357486991713
Rule of 40 score: 10.640025326471486
Financial ratios for TRGP — annual report dated 2025-12-31
Total revenue: 17028300000
Gross profit: 5005200000
Operating income: 3331200000
Net income: 1956700000
Capital expenditures: 3333300000
Operating cash flow: 3917400000
Depreciation & amortization: 1515300000
Net tangible assets: 1416500000
Owner earnings: 138700000
Return on net tangible assets (%): 9.791740204729967
Capex to operating income (%): 100.06304034582132
Buffett classification: The Gruesome
Stock price: 182.67
P/E ratio: 20.038330741048703
Shares outstanding: 214643903
Book value: 3198200000
P/B ratio: 12.25970913670502
Market cap (USD): 39209001761.009995
Debt to equity: 5.478706772559565
Current ratio: 0.666149768805684
Quick ratio: 0.5451110860493966
Effective tax rate (%): 21.30389317889318
Interest coverage ratio: 3.9061913696060038
COGS to revenue (%): 70.6065784605627
SG&A to revenue (%): 2.384266192162459
Free cash flow (dilution-adjusted): 514600000
Buyback yield (%): 1.6368690126618204
Retained earnings: 2294400000
Inventory turnover: 28.0062893081761
Receivables turnover: 11.547741760477418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.371269310987651
FCF margin (%): 3.022028035681777
Revenue growth (%): 3.948356377621097
Rule of 40 score: 6.970384413302874
Financial ratios for TRS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.05
Shares outstanding: 35827685
Market cap (USD): 1291588044.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRS — annual report dated 2022-12-31
Total revenue: 883830000
Gross profit: 208300000
Operating income: 77110000
Net income: 66170000
Capital expenditures: 28790000
Operating cash flow: 72570000
Depreciation & amortization: 53220000
Net tangible assets: 123910000
Owner earnings: 90600000
Return on net tangible assets (%): 73.11758534420144
Capex to operating income (%): 37.33627285695759
Buffett classification: The Good
Stock price: 27.18
P/E ratio: 14.716585738249961
Shares outstanding: 35827685
Book value: 651830000
P/B ratio: 1.4939424056886
Market cap (USD): 973796478.3
Debt to equity: 0.6811898807971404
Current ratio: 3.015768819122369
Quick ratio: 1.8501605422761327
Effective tax rate (%): 24.523782365689517
Interest coverage ratio: 5.4649184975194895
COGS to revenue (%): 76.43211929896022
SG&A to revenue (%): 14.843352228369708
Free cash flow (dilution-adjusted): 16770000
Buyback yield (%): 3.7913466337907584
Retained earnings: -36130000
Inventory turnover: 4.135222820763957
Receivables turnover: 6.676966079927476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.6197364467528015
FCF margin (%): 1.897423712704932
Rule of 40 score: 1.897423712704932
Financial ratios for TRS — annual report dated 2023-12-31
Total revenue: 652150000
Gross profit: 153300000
Operating income: 50840000
Net income: 40360000
Capital expenditures: 480000
Operating cash flow: 88160000
Depreciation & amortization: 57590000
Net tangible assets: 138160000
Owner earnings: 97470000
Return on net tangible assets (%): 70.54863925883033
Capex to operating income (%): 0.9441384736428009
Buffett classification: The Great
Stock price: 24.97
P/E ratio: 22.165938911050542
Shares outstanding: 35827685
Book value: 682950000
P/B ratio: 1.3099308799326452
Market cap (USD): 894617294.4499999
Debt to equity: 0.6490226224467384
Current ratio: 2.492191909689558
Quick ratio: 1.285230479774224
Effective tax rate (%): 17.601115760111576
Interest coverage ratio: 3.193467336683417
COGS to revenue (%): 76.49313808172965
SG&A to revenue (%): 15.711109407344937
Free cash flow (dilution-adjusted): 24300000
Buyback yield (%): 2.099221657853789
Retained earnings: 4230000
Inventory turnover: 2.59210184463497
Receivables turnover: 4.4055259069107615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.300420399083073
FCF margin (%): 3.7261366250095835
Revenue growth (%): -26.213185793648098
Rule of 40 score: -22.487049168638514
Financial ratios for TRS — quarterly report dated 2024-09-30
Capital expenditures: 3870000
Buffett classification: The Gruesome
Stock price: 25.29
Shares outstanding: 35827685
Market cap (USD): 906082153.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0